ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

METRELEPTINUM

Active substance (INN) · ATC A16AA07 · 3 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
A16AA07	METRELEPTINUM	In force	medicine of the protocol	C1-G22	NO

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
MYALEPTA 11,3 mg	PULB. PT. SOL. INJ.	11,3 mg	CHIESI FARMACEUTICI S.P.A. - ITALIA	A16AA07	PR
MYALEPTA 3 mg	PULB. PT. SOL. INJ.	3 mg	CHIESI FARMACEUTICI S.P.A. - ITALIA	A16AA07	PR
MYALEPTA 5,8 mg	PULB. PT. SOL. INJ.	5,8 mg	CHIESI FARMACEUTICI S.P.A. - ITALIA	A16AA07	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.